Based on the GlaxoSmithKline PLC ADR stock forecast from 3 analysts, the average analyst target price for GlaxoSmithKline PLC ADR is USD 42.38 over the next 12 months. GlaxoSmithKline PLC ADR’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of GlaxoSmithKline PLC ADR is Neutral, which is based on 3 positive signals and 3 negative signals. At the last closing, GlaxoSmithKline PLC ADR’s stock price was USD 36.64. GlaxoSmithKline PLC ADR’s stock price has changed by +1.30% over the past week, +9.60% over the past month and -13.09% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for GSK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
